<?xml version='1.0' encoding='utf-8'?>
<document id="20186406"><sentence text="Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects."><entity charOffset="37-45" id="DDI-PubMed.20186406.s1.e0" text="diazepam" /></sentence><sentence text="It has been reported that Ginkgo biloba extract (GBE) is an inducer or inhibitor of microsomal cytochrome P450 (CYP) 2C19, and diazepam is a substrate of CYP2C19"><entity charOffset="127-135" id="DDI-PubMed.20186406.s2.e0" text="diazepam" /></sentence><sentence text=" Thus, it could be expected that GBE may alter the metabolism of diazepam"><entity charOffset="65-73" id="DDI-PubMed.20186406.s3.e0" text="diazepam" /></sentence><sentence text="" /><sentence text="The pharmacokinetic parameters of diazepam and one of its metabolites, N-demethyldiazepam, were compared after oral administration of diazepam (10 mg) in the absence or presence of oral GBE (120 mg bid, for 28 days) in 12 healthy volunteers"><entity charOffset="34-42" id="DDI-PubMed.20186406.s5.e0" text="diazepam" /><entity charOffset="71-89" id="DDI-PubMed.20186406.s5.e1" text="N-demethyldiazepam" /><entity charOffset="134-142" id="DDI-PubMed.20186406.s5.e2" text="diazepam" /><pair ddi="false" e1="DDI-PubMed.20186406.s5.e0" e2="DDI-PubMed.20186406.s5.e0" /><pair ddi="false" e1="DDI-PubMed.20186406.s5.e0" e2="DDI-PubMed.20186406.s5.e1" /><pair ddi="false" e1="DDI-PubMed.20186406.s5.e0" e2="DDI-PubMed.20186406.s5.e2" /><pair ddi="false" e1="DDI-PubMed.20186406.s5.e1" e2="DDI-PubMed.20186406.s5.e1" /><pair ddi="false" e1="DDI-PubMed.20186406.s5.e1" e2="DDI-PubMed.20186406.s5.e2" /></sentence><sentence text=" The pharmacokinetic analysis was performed using a noncompartmental method" /><sentence text="" /><sentence text="The 90% confidence intervals (CIs) of the ratios of mean pharmacokinetic parameters of diazepam presence and absence of GBE were well within the 80-125% bioequivalence range, indicating no pharmacokinetic interaction"><entity charOffset="87-95" id="DDI-PubMed.20186406.s8.e0" text="diazepam" /></sentence><sentence text=" The ratio of AUC(0-408) with GBE to AUC(0-408) without GBE was 95"><entity charOffset="14-24" id="DDI-PubMed.20186406.s9.e0" text="AUC(0-408)" /></sentence><sentence text="2 (90%CI: 91" /><sentence text="6-98" /><sentence text="8) and 101" /><sentence text="8 (90%CI: 99" /><sentence text="4-104" /><sentence text="1) for diazepam and N-desmethyldiazepam, respectively"><entity charOffset="7-15" id="DDI-PubMed.20186406.s15.e0" text="diazepam" /><entity charOffset="20-39" id="DDI-PubMed.20186406.s15.e1" text="N-desmethyldiazepam" /><pair ddi="false" e1="DDI-PubMed.20186406.s15.e0" e2="DDI-PubMed.20186406.s15.e0" /><pair ddi="false" e1="DDI-PubMed.20186406.s15.e0" e2="DDI-PubMed.20186406.s15.e1" /></sentence><sentence text=" The two drugs were well tolerated, and no drug-related serious adverse events were reported" /><sentence text="" /><sentence text="The above data suggest that GBE, when taken in normally recommended doses over a 4-week time period, may not affect the pharmacokinetics of diazepam via CYP2C19 and the excretion of N-desmethyldiazepam in healthy volunteers"><entity charOffset="140-148" id="DDI-PubMed.20186406.s18.e0" text="diazepam" /><entity charOffset="182-201" id="DDI-PubMed.20186406.s18.e1" text="N-desmethyldiazepam" /><pair ddi="false" e1="DDI-PubMed.20186406.s18.e0" e2="DDI-PubMed.20186406.s18.e0" /><pair ddi="false" e1="DDI-PubMed.20186406.s18.e0" e2="DDI-PubMed.20186406.s18.e1" /></sentence><sentence text=" No drug-drug interaction was observed between GBE and diazepam"><entity charOffset="55-63" id="DDI-PubMed.20186406.s19.e0" text="diazepam" /></sentence><sentence text="" /></document>